The role of TNF-α in mice with type 1- and 2- diabetes

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Koulmanda, Maria ^a   Bhasin, Manoj ^a   Awdeh, Zuheir ^b   Qipo, Andi ^a   Fan, Zhigang ^a   Hanidziar, Dusan ^a   Putheti, Prabhakar ^a   Shi, Hang ^c   Csizuadia, Eva ^a   Libermann, Towia A ^a   Strom, Terry B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Pulsar Clinical Technologies Inc   (United States)

^c WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; INSULIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; IMMUNOLOGICAL TOLERANCE; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; TREATMENT RESPONSE; ADIPOSE TISSUE; ANIMAL; BLOOD; C57BL MOUSE; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETICS; IMMUNOLOGY; LYMPH NODE; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SYSTEMS BIOLOGY;

MUS;

ADIPOSE TISSUE; ALPHA 1-ANTITRYPSIN; ANIMALS; ANTIBODIES, MONOCLONAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; IMMUNE TOLERANCE; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; SYSTEMS BIOLOGY; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84860992385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033254     Document Type: Article

References (27)

1. Anderson MS, Bluestone JA, (2005) The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23: 447-485.
2. Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, et al. (2005) A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 23: 115-126.
3. Chaparro RJ, Konigshofer Y, Beilhack GF, Shizuru JA, McDevitt HO, et al. (2006) Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes. Proc Natl Acad Sci U S A 103: 12475-12480.
4. Koulmanda M, Bhasin M, Hoffman L, Fan Z, Qipo A, et al. (2008) Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci U S A 105: 16242-16247.
5. Koulmanda M, Budo E, Bonner-Weir S, Qipo A, Putheti P, et al. (2007) Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts. Proc Natl Acad Sci U S A 104: 13074-13079.
6. Belghith M, Bluestone JA, Barriot S, Megret J, Bach JF, et al. (2003) TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 9: 1202-1208.
7. Bresson D, Togher L, Rodrigo E, Chen Y, Bluestone JA, et al. (2006) Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs. J Clin Invest 116: 1371-1381.
8. Ogawa N, List JF, Habener JF, Maki T, (2004) Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 53: 1700-1705.
9. Tarbell KV, Petit L, Zuo X, Toy P, Luo X, et al. (2007) Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med 204: 191-201.
10. Herold KC, Hagopian W, Auger JA, Poumian-Ruiz E, Taylor L, et al. (2002) Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 346: 1692-1698.
11. Keymeulen B, Vandemeulebroucke E, Ziegler AG, Mathieu C, Kaufman L, et al. (2005) Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 352: 2598-2608.
12. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H, (1990) Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc Natl Acad Sci U S A 87: 968-972.
13. Yang XD, Tisch R, Singer SM, Cao ZA, Liblau RS, et al. (1994) Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med 180: 995-1004.
14. Green EA, Flavell RA, (1999) Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice. Immunol Rev 169: 11-22.
15. Ban L, Zhang J, Wang L, Kuhtreiber W, Burger D, et al. (2008) Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism. Proc Natl Acad Sci U S A 105: 13644-13649.
16. Kodama S, Kuhtreiber W, Fujimura S, Dale EA, Faustman DL, (2003) Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 302: 1223-1227.
17. Hutchings P, Rosen H, O'Reilly L, Simpson E, Gordon S, et al. (1990) Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages. Nature 348: 639-642.
18. Lee KU, Amano K, Yoon JW, (1988) Evidence for initial involvement of macrophage in development of insulitis in NOD mice. Diabetes 37: 989-991.
19. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM, (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 94: 1543-1549.
20. Mastrandrea L, Yu J, Behrens T, Buchlis J, Albini C, et al. (2009) Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study. Diabetes Care 32: 1244-1249.
21. Feldmann M, (2009) Translating molecular insights in autoimmunity into effective therapy. Annu Rev Immunol 27: 1-27.
22. Jones J, Otu H, Spentzos D, Kolia S, Inan M, et al. (2005) Gene signatures of progression and metastasis in renal cell cancer. Clin Cancer Res 11: 5730-5739.
23. Wilson CL, Miller CJ, (2005) Simpleaffy: a BioConductor package for Affymetrix Quality Control and data analysis. Bioinformatics 21: 3683-3685.
24. Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, et al. (2006) RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22: 2825-2827.
25. In't Veld P, (2011) Insulitis in human type 1 diabetes: The quest for an elusive lesion. Islets 3: 131-138.
26. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP, (1985) An improved method for isolation of mouse pancreatic islets. Transplantation 40: 437-438.
27. Xu G, Stoffers DA, Habener JF, Bonner-Weir S, (1999) Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48: 2270-2276.